Skip to main content

The Institute of Medicine White Paper on Testosterone: Current Perspective

  • Chapter
  • First Online:
Androgen Deficiency and Testosterone Replacement

Part of the book series: Current Clinical Urology ((CCU))

  • 1071 Accesses

Abstract

Good health and normal sexual function in males require functioning testicles, a fact known since antiquity. It is only more recently that the source of that effect was attributed to testosterone. Several centuries ago, Arnould Berthold castrated a rooster as part of an experiment, which resulted in loss of the physical signs of masculinization. Berthold realized that something manufactured by the testes was responsible for maintenance of virilization; returning the testicles to the intra-abdominal cavity of the rooster led to a restoration of its phenotype. Because Berthold had severed the neurovascular connection of the testis to the body, he correctly surmised that the testicles produced a secretion that must act through the circulatory system. It was Charles Brown-Sequard who confirmed the testes as the source of the secretion of this “hormone.” After he extracted fluid from the testis of dogs and injected himself with this fluid, he experienced improvements in strength, appetite, and mentation and published the results. The exact chemical messenger remained unidentified until 1935, when David et al. published the structure of the steroidal chemical and named the compound “testosterone.” Shortly thereafter, Butenandt and Ruzicka published near simultaneous manuscripts describing the methods for testosterone synthesis, which resulted in them subsequently sharing the Nobel Prize.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Freeman ER, Bloom DA, McGuire EJ. A brief history of testosterone. J Urol. 2001;165(2):371–3.

    Article  PubMed  CAS  Google Scholar 

  2. Schultheiss D, Denil J, Jonas U. Rejuvenation in the early 20th century. Andrologia. 1997;29(6):351–5.

    Article  PubMed  CAS  Google Scholar 

  3. Liverman CT, Blazer DG, editors. Testosterone and aging: clinical research directions. Washington, DC: National Academies Press; 2004.

    Google Scholar 

  4. Basar MM, Aydin G, Mert HC, et al. Relationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile Function. Urology. 2005;66(3):597–601.

    Article  PubMed  Google Scholar 

  5. Blumel JE, Chedraui P, Gili SA, Navarro A, Valenzuela K, Vallejo S. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men? Maturitas. 2009;63(4):365–8.

    Article  PubMed  Google Scholar 

  6. Lackner JE, Rucklinger E, Schatzl G, Lunglmayr G, Kratzik CW. Are there symptom-specific testosterone thresholds in aging men? BJU Int. 2011;108(8):1310–5.

    Article  PubMed  CAS  Google Scholar 

  7. Gades NM, Jacobson DJ, McGree ME, et al. The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among men. J Sex Med. 2008;5(9):2209–20.

    PubMed  Google Scholar 

  8. Corona G, Jannini EA, Mannucci E, et al. Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med. 2008;5(8):1991–8.

    Article  PubMed  CAS  Google Scholar 

  9. Seftel AD, Mack RJ, Secrest AR, Smith TM. Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning. J Androl. 2004;25(6):963–72.

    PubMed  Google Scholar 

  10. Isidori AM, Giannetta E, Gianfrilli D, et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol. 2005;63(4):381–94.

    Article  CAS  Google Scholar 

  11. Finas D, Bals-Pratsch M, Sandmann J, et al. Quality of life in elderly men with androgen deficiency. Andrologia. 2006;38(2):48–53.

    Article  PubMed  CAS  Google Scholar 

  12. T’Sjoen G, Goemaere S, De Meyere M, Kaufman JM. Perception of males’ aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology. 2004;29(2):201–14.

    Article  PubMed  Google Scholar 

  13. Hogervorst E, Combrinck M, Smith AD. Testosterone and gonadotropin levels in men with dementia. Neuro Endocrinol Lett. 2003;24(3–4):203–8.

    PubMed  CAS  Google Scholar 

  14. Almeida OP, Yeap BB, Hankey GJ, Jamrozik K, Flicker L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry. 2008;65(3):283–9.

    Article  PubMed  CAS  Google Scholar 

  15. Giltay EJ, Tishova YA, Mskhalaya GJ, Gooren LJG, Saad F, Kalinchenko SY. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. J Sex Med. 2010;7(7):2572–82.

    PubMed  CAS  Google Scholar 

  16. Schaap LA, Pluijm SMF, Smit JH, et al. The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. Clin Endocrinol. 2005;63(2):152–60.

    Article  CAS  Google Scholar 

  17. Travison TG, Nguyen A-H, Naganathan V, et al. Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project. J Clin Endocrinol Metabol. 2011;96(8):2464–74.

    Article  CAS  Google Scholar 

  18. Cawthon PM, Ensrud KE, Laughlin GA, et al. Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metabol. 2009;94(10):3806–15.

    Article  CAS  Google Scholar 

  19. Mohr BA, Bhasin S, Kupelian V, Araujo AB, O’Donnell AB, McKinlay JB. Testosterone, sex hormone-binding globulin, and frailty in older men. J Am Geriatr Soc. 2007;55(4):548–55.

    Article  PubMed  Google Scholar 

  20. Tajar A, O’Connell MDL, Mitnitski AB, et al. Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: results from the European male aging study. J Am Geriatr Soc. 2011;59(5):814–21.

    Article  PubMed  Google Scholar 

  21. Hyde Z, Flicker L, Almeida OP, et al. Low free testosterone predicts frailty in older men: the health in men study. J Clin Endocrinol Metabol. 2010;95(7):3165–72.

    Article  CAS  Google Scholar 

  22. Kenny AM, Kleppinger A, Annis K, et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty. J Am Geriatr Soc. 2010;58(6):1134–43.

    Article  PubMed  Google Scholar 

  23. Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metabol. 2010;95(2):639–50.

    Article  CAS  Google Scholar 

  24. Permpongkosol S, Tantirangsee N, Ratana-olarn K. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints. J Sex Med. 2010;7(11):3765–74.

    Article  PubMed  CAS  Google Scholar 

  25. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci. 2003;58(7):618–25.

    Article  PubMed  Google Scholar 

  26. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109–22.

    Article  PubMed  CAS  Google Scholar 

  27. Cook NL, Romashkan S. Why do we need a trial on the effects of testosterone therapy in older men? Clin Pharmacol Ther. 2011;89(1):29–31.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclaimer The opinions expressed by the author are his alone and do not reflect those of Eli Lilly & Company.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Craig F. Donatucci MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Donatucci, C.F. (2013). The Institute of Medicine White Paper on Testosterone: Current Perspective. In: Hellstrom, W. (eds) Androgen Deficiency and Testosterone Replacement. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-179-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-179-0_1

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-178-3

  • Online ISBN: 978-1-62703-179-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics